Terms: = Lung cancer AND HOXD13, SPD, 3239, P35453, HOX4I AND Diagnosis
20 results:
1. The Expression and Prognostic Significance of ICOS in NSCLC Integrated Pan-cancer and Multi-Omics Analyses.
Chen M; Yan X; Hong B; Xiao Y; Qian Y
Int J Med Sci; 2024; 21(5):795-808. PubMed ID: 38616999
[No Abstract] [Full Text] [Related]
2. spd-L1 and spd-L2 in plasma of patients with lung cancer and their clinical significance.
Han S; Zhang Y; Yuan J; Wu Y; Zhou Y; Zhou Y; Li X; Zhou S
Cytokine; 2024 Apr; 176():156532. PubMed ID: 38330638
[TBL] [Abstract] [Full Text] [Related]
3. Subcutaneous Leiomyosarcoma: An Aggressive Malignancy Portending a Significant Risk of Metastasis and Death.
Bresler SC; Gosnell HL; Ko JS; Angeles CV; Ronen S; Billings SD; Patel RM
Am J Surg Pathol; 2023 Dec; 47(12):1417-1424. PubMed ID: 37727934
[TBL] [Abstract] [Full Text] [Related]
4. Clinicoradiological course of abemaciclib-induced pneumonitis with histology findings.
Okayasu K; Kawasaki T; Kumagai J; Miyazaki Y
BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130630
[TBL] [Abstract] [Full Text] [Related]
5. Sex difference in the expression of PD-1 of non-small cell lung cancer.
Gu Y; Tang YY; Wan JX; Zou JY; Lu CG; Zhu HS; Sheng SY; Wang YF; Liu HC; Yang J; Hong H
Front Immunol; 2022; 13():1026214. PubMed ID: 36341395
[TBL] [Abstract] [Full Text] [Related]
6. Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levels.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Okada M
Thorac Cancer; 2022 Nov; 13(22):3200-3207. PubMed ID: 36178187
[TBL] [Abstract] [Full Text] [Related]
7. A comprehensive profiling of soluble immune checkpoints from the sera of patients with non-small cell lung cancer.
Peng Y; Zhang C; Rui Z; Tang W; Xu Y; Tao X; Zhao Q; Tong X
J Clin Lab Anal; 2022 Feb; 36(2):e24224. PubMed ID: 35019173
[TBL] [Abstract] [Full Text] [Related]
8. Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With lung and Gastric cancer Treated With Immune Checkpoint Inhibitors.
Ando K; Hamada K; Watanabe M; Ohkuma R; Shida M; Onoue R; Kubota Y; Matsui H; Ishiguro T; Hirasawa Y; Ariizumi H; Tsurutani J; Yoshimura K; Tsunoda T; Kobayashi S; Wada S
Anticancer Res; 2019 Sep; 39(9):5195-5201. PubMed ID: 31519633
[TBL] [Abstract] [Full Text] [Related]
9. [A Case of Drug-Induced Interstitial lung Disease Associated with Epirubicin and Cyclophosphamide Therapy before Operation].
Omoto H; Takada M; Fujii S; Ito H; Yamashita S
Gan To Kagaku Ryoho; 2019 Jan; 46(1):160-162. PubMed ID: 30765674
[TBL] [Abstract] [Full Text] [Related]
10. Screening of anticancer drugs to detect drug-induced interstitial pneumonia using the accumulated data in the electronic medical record.
Shimai Y; Takeda T; Okada K; Manabe S; Teramoto K; Mihara N; Matsumura Y
Pharmacol Res Perspect; 2018 Jul; 6(4):e00421. PubMed ID: 30009034
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Course of Histologically Proven Multifocal Micronodular Pneumocyte Hyperplasia in Tuberous Sclerosis Complex: A Case Series and Comparison with Lymphangiomyomatosis.
Konno S; Shigemura M; Ogi T; Shimizu K; Suzuki M; Kaga K; Hida Y; Matsuno Y; Nishimura M
Respiration; 2018; 95(5):310-316. PubMed ID: 29393256
[TBL] [Abstract] [Full Text] [Related]
12. Correlation analysis of surfactant protein A and surfactant protein D with lung function in exhaled breath condensate from lung cancer patients with and without COPD.
Lin X; Wu Z; Fan Y; Chi M; Wang X; Zhang X; Sun D
Mol Med Rep; 2017 Oct; 16(4):4948-4954. PubMed ID: 28791362
[TBL] [Abstract] [Full Text] [Related]
13. Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy.
Zhao J; Zhang P; Wang J; Xi Q; Zhao X; Ji M; Hu G
Medicine (Baltimore); 2017 Feb; 96(7):e6102. PubMed ID: 28207525
[TBL] [Abstract] [Full Text] [Related]
14. Simultaneous determination of polyamines in human nail as 4-(N,N-dimethylaminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole derivatives by nano-flow chip LC coupled with quadrupole time-of-flight tandem mass spectrometry.
Min JZ; Yano H; Matsumoto A; Yu HF; Shi Q; Higashi T; Inagaki S; Toyo'oka T
Clin Chim Acta; 2011 Jan; 412(1-2):98-106. PubMed ID: 20869356
[TBL] [Abstract] [Full Text] [Related]
15. DNA methylation markers of surfactant proteins in lung cancer.
Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
[TBL] [Abstract] [Full Text] [Related]
16. Great potential of a panel of multiple hMTH1, spd, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.
Chong IW; Chang MY; Chang HC; Yu YP; Sheu CC; Tsai JR; Hung JY; Chou SH; Tsai MS; Hwang JJ; Lin SR
Oncol Rep; 2006 Nov; 16(5):981-8. PubMed ID: 17016581
[TBL] [Abstract] [Full Text] [Related]
17. Effectiveness of transbronchial needle aspiration in the diagnosis of exophytic endobronchial lesions and submucosal/peribronchial diseases of the lung.
Kaçar N; Tuksavul F; Edipoğlu O; Ermete S; Güçlü SZ
Lung Cancer; 2005 Nov; 50(2):221-6. PubMed ID: 16046029
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
Sasaki R; Soejima T; Matsumoto A; Maruta T; Yamada K; Ota Y; Kawabe T; Nishimura H; Sakai E; Ejima Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):301-7. PubMed ID: 11380215
[TBL] [Abstract] [Full Text] [Related]
19. [The examinations for diffuse lung diseases].
Otake K; Suwabe A; Tominaga M
Rinsho Byori; 2000 Dec; 48(12):1112-7. PubMed ID: 11215419
[TBL] [Abstract] [Full Text] [Related]
20. Utility of transbronchial needle aspiration in the diagnosis of endobronchial lesions.
Dasgupta A; Jain P; Minai OA; Sandur S; Meli Y; Arroliga AC; Mehta AC
Chest; 1999 May; 115(5):1237-41. PubMed ID: 10334133
[TBL] [Abstract] [Full Text] [Related]
